Published in Europace on June 24, 2013
Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review. Eur Heart J (2015) 1.42
Chronotropic incompetence in Chagas disease: usefulness of dual sensor pacemaker based on volume minute and accelerometer. Rev Bras Cir Cardiovasc (2015) 1.39
Better management of out-of-hospital cardiac arrest increases survival rate and improves neurological outcome in the Swiss Canton Ticino. Europace (2015) 1.38
Necessary clarifications and minor corrections: Letter to the Editor regarding '2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy'. Europace (2013) 1.08
MRI and cardiac implantable electronic devices; current status and required safety conditions. Neth Heart J (2014) 1.03
Safe performance of magnetic resonance of the heart in patients with magnetic resonance conditional pacemaker systems: the safety issue of the ESTIMATE study. J Cardiovasc Magn Reson (2014) 0.98
Complications after Surgical Procedures in Patients with Cardiac Implantable Electronic Devices: Results of a Prospective Registry. Arq Bras Cardiol (2016) 0.97
Atrial synchronous left ventricular only pacing with VDD pacemaker system - a cost effective alternative to conventional cardiac resynchronization therapy. Indian Heart J (2014) 0.96
Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays. Neth Heart J (2016) 0.89
Heart failure and atrial fibrillation: from basic science to clinical practice. Int J Mol Sci (2015) 0.87
Changes in electrical activation modify the orientation of left ventricular flow momentum: novel observations using echocardiographic particle image velocimetry. Eur Heart J Cardiovasc Imaging (2015) 0.84
Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical Outcome. PLoS One (2015) 0.84
Diagnosis, pathophysiology, and management of exercise-induced arrhythmias. Nat Rev Cardiol (2016) 0.83
Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K⁺ channel-deficient dilated cardiomyopathy. J Am Heart Assoc (2013) 0.82
Implantable cardioverter defibrillators in octogenarians: clinical outcomes from a single center. Indian Pacing Electrophysiol J (2015) 0.82
Cardiac Resynchronization Therapy prevents progression of renal failure in heart failure patients. Indian Pacing Electrophysiol J (2016) 0.81
Arrhythmias in the Heart Transplant Patient. Arrhythm Electrophysiol Rev (2014) 0.79
Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming. World J Cardiol (2014) 0.79
Cardiac Resynchronisation Therapy or MitraClip® Implantation for Patients with Severe Mitral Regurgitation and Left Bundle Branch Block? Arrhythm Electrophysiol Rev (2014) 0.79
Carotid sinus syndrome: Progress in understanding and management. Glob Cardiol Sci Pract (2014) 0.78
Magnetic resonance imaging and devices: a mesmerising combination. Neth Heart J (2014) 0.78
The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy. Europace (2015) 0.78
Ventricular tachycardias in patients with pulmonary hypertension: an underestimated prevalence? A prospective clinical study. Herzschrittmacherther Elektrophysiol (2015) 0.77
Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy. J Am Heart Assoc (2015) 0.77
Developments in Cardiac Resynchronisation Therapy. Arrhythm Electrophysiol Rev (2015) 0.77
Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial. Trials (2014) 0.77
Reparative resynchronization in ischemic heart failure: an emerging strategy. Expert Opin Biol Ther (2014) 0.76
Clinical significance of conduction disturbances after aortic valve intervention: current evidence. Clin Res Cardiol (2014) 0.76
Atrioventricular block in coronary artery bypass surgery: perioperative predictors and impact on mortality. Rev Bras Cir Cardiovasc (2015) 0.75
Ventricular pacing - Electromechanical consequences and valvular function. Indian Pacing Electrophysiol J (2016) 0.75
Cardiac Resynchronisation Therapy: The Optimal QRS Duration Revisited. Arrhythm Electrophysiol Rev (2016) 0.75
Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden. Clinicoecon Outcomes Res (2016) 0.75
Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-Ischemic Heart Failure Patients: A Randomized Crossover Pilot Trial. PLoS One (2015) 0.75
Current Evidence and Recommendations for Cardiac Resynchronisation Therapy. Arrhythm Electrophysiol Rev (2014) 0.75
Clinical Long-Term Response to Cardiac Resynchronization Therapy Is Independent of Persisting Echocardiographic Markers of Dyssynchrony. Cardiol Res (2014) 0.75
Variations of QRS Morphology in Patients with Dilated Cardiomyopathy; Clinical and Prognostic Implications. J Cardiovasc Thorac Res (2014) 0.75
Reversibility of High-Grade Atrioventricular Block with Revascularization in Coronary Artery Disease without Infarction: A Literature Review. Case Rep Cardiol (2016) 0.75
Clinical Relevance Of Systematic CRT Device Optimization. J Atr Fibrillation (2014) 0.75
Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database. Europace (2016) 0.75
Relevance of guideline-based ICD indications to clinical practice. Indian Heart J (2013) 0.75
Comparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy. Yonsei Med J (2017) 0.75
Predictors of left ventricular dysfunction with right ventricular pacing: Is paced QRS duration the answer? Indian Pacing Electrophysiol J (2015) 0.75
Haemodynamic Alterations Induced By Cardiac Pacing: Is Clinical Evaluation Sufficient Or Do We Need Long-Term Device Monitoring? J Atr Fibrillation (2015) 0.75
Cardiac Resynchronization Therapy Device Implantation in a Patient with Cardiogenic Shock under Percutaneous Mechanical Circulatory Support. Korean Circ J (2016) 0.75
Electrophysiological Testing for the Investigation of Bradycardias. Arrhythm Electrophysiol Rev (2017) 0.75
Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators. J Magn Reson Imaging (2015) 0.75
Magnetic Resonance Imaging for Patients with Cardiac Implantable Electronic Devices: Reduced Concerns Regarding Safety, but Scrutiny Remains Critical. Korean Circ J (2016) 0.75
The risk of ventricular arrhythmias in a Dutch CRT population: CRT-defibrillator versus CRT-pacemaker. Neth Heart J (2016) 0.75
Rare Cause of Wide QRS Tachycardia. Case Rep Cardiol (2015) 0.75
Mobile thrombus on cardiac implantable electronic device leads of patients undergoing cardiac ablation: incidence, management, and outcomes. J Interv Card Electrophysiol (2015) 0.75
Automated detection of effective left-ventricular pacing: going beyond percentage pacing counters. Europace (2015) 0.75
[Inappropriate ICD therapies: All problems solved with MADIT-RIT?]. Herzschrittmacherther Elektrophysiol (2015) 0.75
Left univentricular pacing for cardiac resynchronization therapy using rate-adaptive atrioventricular delay. J Geriatr Cardiol (2017) 0.75
[Antibradycardia therapy : Indication and implementation]. Herzschrittmacherther Elektrophysiol (2016) 0.75
Non-contrast cardiac resynchronization therapy implantation is feasible in case of renal insufficiency. J Interv Card Electrophysiol (2015) 0.75
Cardiovascular implantable electronic devices: a review of the dangers and difficulties in MR scanning and attempts to improve safety. Insights Imaging (2017) 0.75
QRS prolongation after cardiac resynchronization therapy is a predictor of persistent mechanical dyssynchrony. J Interv Card Electrophysiol (2015) 0.75
Dual-Chamber Stimulation with Single-Lead VDD Pacing System in Mustard Surgery. Pediatr Cardiol (2015) 0.75
Anemia and its association with clinical outcome in heart failure patients undergoing cardiac resynchronization therapy. J Interv Card Electrophysiol (2015) 0.75
2:1 AV block : The orphan of organizational guidelines for cardiac pacing. Herzschrittmacherther Elektrophysiol (2016) 0.75
Efficacy of optimal medical therapy and cardiac resynchronization therapy upgrade in patients with pacemaker-induced cardiomyopathy. J Interv Card Electrophysiol (2015) 0.75
Is There a Future for Remote Cardiac Implantable Electronic Device Management? Arrhythm Electrophysiol Rev (2017) 0.75
Left ventricular performance during triggered left ventricular pacing in patients with cardiac resynchronization therapy and left bundle branch block. J Interv Card Electrophysiol (2016) 0.75
The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI. J Interv Card Electrophysiol (2016) 0.75
[Implantable cardioverter-defibrillator: Is remote monitoring obligatory?]. Herzschrittmacherther Elektrophysiol (2015) 0.75
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Subclinical atrial fibrillation and the risk of stroke. N Engl J Med (2012) 11.11
Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26
Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J (2009) 8.25
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 7.75
Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation (2008) 7.11
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation (2010) 5.68
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J (2014) 5.21
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11
Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med (2004) 4.99
Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation (2008) 4.43
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol (2003) 4.36
Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol (2002) 3.77
Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J (2007) 3.65
A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol (2009) 3.61
Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol (2005) 3.58
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 3.50
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol (2010) 3.50
Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol (2005) 3.46
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA (2007) 3.32
The way forward. Lancet (2007) 3.28
Concern Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J (2009) 3.14
Evidence of structural remodeling in the dyssynchronous failing heart. Circ Res (2005) 3.05
Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J (2004) 3.02
Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation (2011) 3.00
Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm (2010) 2.89
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol (2011) 2.84
Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation (2012) 2.80
Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol (2008) 2.75
Institutional delivery in rural India: the relative importance of accessibility and economic status. BMC Pregnancy Childbirth (2010) 2.69
Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography. Eur Heart J (2007) 2.59
Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol (2006) 2.56
Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation (2012) 2.53
Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation (2004) 2.50
Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol (2008) 2.50
Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 2.49
Atrial fibrillation in trauma patients requiring intensive care. Intensive Care Med (2006) 2.49
Guidelines on management (diagnosis and treatment) of syncope--update 2004. Europace (2004) 2.47
Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab (2003) 2.42
Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (2004) 2.40
HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm (2010) 2.35
Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol (2006) 2.33
Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace (2009) 2.33
Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years. J Am Coll Cardiol (2006) 2.30
Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J (2008) 2.29
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol (2012) 2.28
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J (2005) 2.28
Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol (2002) 2.22
Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol (2009) 2.21
Classifying fractionated electrograms in human atrial fibrillation using monophasic action potentials and activation mapping: evidence for localized drivers, rate acceleration, and nonlocal signal etiologies. Heart Rhythm (2010) 2.19
Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol (2002) 2.19
Feasibility of diastolic function assessment with cardiac CT: feasibility study in comparison with tissue Doppler imaging. JACC Cardiovasc Imaging (2011) 2.18
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. J Am Coll Cardiol (2009) 2.16
Experimental validation of circumferential, longitudinal, and radial 2-dimensional strain during dobutamine stress echocardiography in ischemic conditions. J Am Coll Cardiol (2008) 2.15